, Volume 24, Issue 4, pp 224–230 | Cite as

The genetic susceptibility to type 1 (insulin-dependent) diabetes: Analysis of the HLA-DR association

  • E. Wolf
  • K. M. Spencer
  • A. G. Cudworth


HLA-DR and MT1, MT2, MT3 genotypes have been investigated in 123 Type 1 (insulin-dependent) diabetic subjects and their families. Ninety-eight percent of probands possessed either DR3 (relative risk = 5.0), or DR4 (relative risk = 6.8) or both antigens (relative risk = 14.3), emphasizing the strong association of the disease with these two antigens. Almost 51% of the probands were DR3, DR4 heterozygotes. The DR antigen combinations of the parents leading to DR3, DR4 heterozygous and to DR3 and DR4 homozygous offspring were analysed. There was a marked increase in DR3, DR4 heterozygosity, but no increase in homozygosity for these antigens compared with the expected frequencies. These results are compatible with the existence of two susceptibility genes operating at a locus or at loci closely linked to that of HLA-DR. There was a striking reduction of DR7 (relative risk = 0.1) and only five probands possessed DR2 (relative risk = 0.1). In each case, the other inherited allele was DR3 or DR4. Linkage disequilibrium between B7 and DR2 was much lower in the haplotypes of the probands than in the ‘non-diabetic’ parental haplotype. In contrast, the association of BW62 with DR4 was more pronounced in the haplotypes of the probands. There was no increase in recombination frequency in these families and no strong effect of HLA-DR on age of onset could be demonstrated. There was a significant shift towards DR identity compared with identity for the whole HLA haplotype (A, B, C and DR) in both healthy and diabetic siblings (p < 0.025).

Key words

Type 1 diabetes HLA-DR genotypes genetic susceptibility 


  1. 1.
    Singal DP, Blajchman MA (1973) Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22: 429–432Google Scholar
  2. 2.
    Nerup J, Platz P, Anderson OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Staub-Nielsen L, Thomsen M, Svejgaard A (1974) HL-A antigens and diabetes mellitus. Lancet 2: 864–866Google Scholar
  3. 3.
    Cudworth AG, Woodrow JC (1975) HL-A system and diabetes mellitus. Diabetes 24: 345–349Google Scholar
  4. 4.
    Cudworth AG, Woodrow JC (1975) Evidence for HL-A linked genes in ‘juvenile’ diabetes mellitus. Br Med J 3: 133–135Google Scholar
  5. 5.
    Barbosa J, King R, Noreen H, Yunis EJ (1977) The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin Invest 60: 989–998Google Scholar
  6. 6.
    Svejgaard A, Platz P, Ryder LP, Staub-Nielsen L, Thomsen M (1975) HL-A and disease associations: a survey. Transplant Rev 22: 3–43Google Scholar
  7. 7.
    Batchelor JR, Morris PJ (1977) Joint report on HLA and disease: juvenile onset diabetes. In: Bodmer WF, Batchelor JR, Bodmer JC, Festenstein H, Morris PJ (eds) Histocompatibility testing. Munksgaard, Copenhagen, pp 211–213Google Scholar
  8. 8.
    Svejgaard A, Platz P, Ryder LP (1980) Joint report: insulindependent diabetes mellitus. In: Terasaki PI (ed) Histocompatibility testing. 1980. UCLA, Tissue Typing Laboratory, California, pp 638–656Google Scholar
  9. 9.
    Spielman RS, Baker L, Zmijewski CM (1980) Gene dosage and susceptibility to insulin-dependent diabetes. Ann Hum Genet 44: 135–150Google Scholar
  10. 10.
    Thomson G (1980) A two locus model for juvenile diabetes. Ann Hum Genet 43: 383–398Google Scholar
  11. 11.
    Bodmer WF (1980) The HLA system and disease. J R Coll Physicians 14: 43–50Google Scholar
  12. 12.
    Rubinstein P, Suciu-Foca N, Nicholson JF (1977) Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA and with 50% penetrance. N Engl J Med 297: 1036–1040Google Scholar
  13. 13.
    Tosi R, Tanigaki N (1980) Joint report: MT1. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Tissue Typing Laboratory, California, pp 556–563Google Scholar
  14. 14.
    Juji T, Maeda H, Omori K (1980) Joint report: MT2. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Tissue Typing Laboratory, California, pp 564–566Google Scholar
  15. 15.
    Tosi R (1980) Joint report: MT3. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Tissue Typing Laboratory, California, pp 567–569Google Scholar
  16. 16.
    Christy M, Green A, Christau B, Kromann H, Nerup J, Platz P, Thomsen M, Ryder LP, Svejgaard A (1979) Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care 2: 209–214Google Scholar
  17. 17.
    Deschamps I, Lestradet H, Bonaiti C, Schmid M, Busson M, Benajam A, Marcelli-Barge A, Hors J (1980) HLA genotype studies in juvenile insulin-dependent diabetes. Diabetologia 19: 189–193Google Scholar
  18. 18.
    Tosi R, Tanigaki N, Gentis D, Ferrara GB, Pressman D (1978) Immunological dissection of human Ia molecules. J Exp Med 148: 1592–1611Google Scholar
  19. 19.
    Festenstein H, Adams E, Burke J, Oliver RTD, Sachs JA, Wolf E (1973) The distribution of HL-A antigens in expatriates from East Bengal living in London. In: Dausset J, Colombani J (eds) Histocompatibility testing 1972. Munksgaard, Copenhagen, pp 175–178Google Scholar
  20. 20.
    Van Rood JJ, van Leeuwen A, Ploem JS (1976) Simultaneous detection of two cell population by two-colour fluorescence and application to the recognition of B cell determinants. Nature 262: 795–797Google Scholar
  21. 21.
    Haldane JBS (1955) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20: 309–311Google Scholar
  22. 22.
    Bengtsson BO, Thomson G (1981) Measuring the strength of associations between HLA antigens and diseases. Tissue Antigens 18: 356–363Google Scholar
  23. 23.
    Van Leeuwen A, Festenstein H, D'Amaro J, Navarette Ch, Awad J, van Rood JJ (1980) A new B cell locus defined by a recombinant family. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Tissue Typing Laboratory, California, p 853Google Scholar
  24. 24.
    Cudworth AG, Wolf E, Gorsuch AN, Festenstein H (1979) A new look at HLA genetics with particular reference to Type 1 diabetes mellitus. Lancet 2: 389–391Google Scholar
  25. 25.
    Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in Type 1 (insulin-dependent) diabetes mellitus. Lancet 2: 1363–1365Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • E. Wolf
    • 1
  • K. M. Spencer
    • 1
  • A. G. Cudworth
    • 1
  1. 1.Department of Diabetes and Immunogenetics, Medical UnitSt Bartholomew's HospitalLondonUK

Personalised recommendations